The overlapping prevalence of some of these pulmonary diseases and the possible existence of common underlying molecular mechanisms, suggest that targeting similar pathways in pulmonary diseases may be a logical approach to future treatment and indicate that PP2A may be a key pathogenic link in the progression of several pulmonary diseases. Here, PTPA is linked to lung disorder.